My deep brain stimulation
|
|
Deep brain stimulation (DBS) is increasingly being used to treat Parkinson's and other movement disorders. This treatment method involves implanting electrodes into deep brain structures that are connected to a power device. The device is similar to a pacemaker and is implanted in the chest. It can be controlled and adjusted remotely by both doctors and patients.
The stimulation parameters are controlled by a computer to adjust amplitudes, frequencies and pulse widths. Common targets for DBS in Parkinson's disease include the subthalamic nucleus, the internal globus pallidus, and the ventral intermediate nucleus of the thalamus.
Current research shows promising results for DBS in the early stages of Parkinson's disease. A five-year study found that patients who received DBS in the early stages required lower doses of medication and showed long-term motor benefits over standard therapy. This study suggests that early DBS may reduce the need for complex Parkinson's medications.
Advances in DBS technology have resulted in increased programming flexibility, potentially improving therapeutic benefits.
New developments, such as pioneering DBS electrodes, help avoid current spread to structures that could cause side effects. Controlling the current to individual contacts on a DBS electrode allows the electric field between multiple active contacts to be shaped. These advances make DBS an effective treatment option.
More and more experts in the field have recently highlighted the latest developments in DBS technology and emphasized its growing importance in the treatment of Parkinson's disease. Research is also focused on using DBS to improve balance, gait and postural instability in Parkinson's patients, demonstrating the ever-evolving scope of DBS.
The surgical procedure itself includes several key steps:
This surgical procedure is complex and requires a multidisciplinary team of neurosurgeons, neurologists, specialized nurses and sometimes neuropsychologists. DBS does not provide a cure for Parkinson's, but is a way to manage and relieve symptoms, especially when medications are no longer sufficiently effective.
More articles on “Research and Development”
Dear Mr. Zender,
I find your article very interesting, but something crucial is missing, you don't write anything about your condition after the operation. I'm on September 12th. was operated on at the Charité last year. I have significant benefits from the operation, e.g. B. drastic reduction in medication, better sleep, less pain, but there are also disadvantages. Since the operation my walking has deteriorated significantly and I feel very alone. Adjusting the stimulator has not brought any improvement so far. My next appointment for an inpatient setting is on September 18.9.24th, 1, it should take a year until the setting is optimal. I was released from the Charité with the words: what's been a year!
Since I am 70 years old, 1 year of life may be a lot. In any case, my experience is that getting the right setting is very difficult and I don't think I'm the only one who would be grateful for a tip on where to turn. I would be very grateful for feedback.
I'm sorry to hear that it didn't work out so well for you. But I can only report on my operation and there have been no problems to date, on the contrary, I would do it again at any time